Parliamentary.ai


by Munro Research

Parliamentary.ai uses AI technology to produce easily understandable summaries of the bills under consideration in the British Parliament.

Random Bill

Summary of a randomly selected bill, powered by AnyModel.

NHS Prescriptions (Drug Tariff Labelling) Bill

Current Stage: 1st reading

Last updated: 02/11/2023

View full entry


Overview

This bill mandates that community pharmacies and other NHS prescription providers display the Drug Tariff price of dispensed medication on patient labels. This aims to increase transparency in NHS prescription costs.

Description

The NHS Prescriptions (Drug Tariff Labelling) Bill amends the Human Medicines Regulations 2012. Specifically, it adds a requirement for the Drug Tariff price to be included on prescription labels. The Drug Tariff itself varies by nation (England, Wales, Scotland, and Northern Ireland), with the bill specifying the relevant regulations for each. The bill defines "Drug Tariff" for each nation, referencing existing regulations to ensure clarity. The law comes into effect three months after passing, and applies across all four nations of the UK.

Government Spending

The bill is not expected to significantly impact government spending. The cost of implementing the labelling requirement is likely to be minimal, as it primarily involves an adjustment to existing labelling procedures. No specific figures regarding the cost of implementation are provided within the bill itself.

Groups Affected

  • Community Pharmacies: Will need to adjust their labelling processes to include the Drug Tariff price. This may involve additional administrative costs and require updated software or systems.
  • Other NHS Prescription Providers: Similar to pharmacies, these providers will have to adapt their procedures to comply with the new labelling requirements.
  • Patients: Will directly see the Drug Tariff price on their prescription labels, increasing transparency regarding the cost of their medication to the NHS.
More details

Powered by nyModel

DISCLAIMER: AI technology is not 100% accurate and summaries may contain errors, use at your own risk. Munro Research holds the copyright for all summaries found this website. Reproduction for non-commercial purposes is permitted but must be displayed alongside a link to this website. Contact info@munro-research to license commercially.